DexCom DXCM
$79.32 −$0.87 (-1.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $78.18 -1.44%
Open$80.48
Prev close$80.19
Day range$78.75 – $81.58
Volume4.61M
Market cap$29.58B
P/E (TTM)31.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.34B+11.2% YoY
Operating profit$327.20M+34.9% YoY
Net profit$275.10M-3.1% YoY
Diluted EPS$0.72+2.9% YoY
Free cash flow$906.20M+2.4% YoY
Operating cash flow$1.12B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin63.4%
Operating margin24.0%
Net margin19.4%
Return on equity37.7%
Return on assets14.4%
Return on invested capital20.4%
Current ratio1.74
Liabilities / assets59.4%
Cash & investments$1.82B
Total debt$1.37B
Net cash (debt)$445.70M
Free cash flow / sales33.9%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.34B | $1.31B | $1.19B | $4.66B | $1.26B |
| Total Operating Revenue | $1.34B | $1.31B | $1.19B | $4.66B | $1.26B |
| Cost of Revenue | $480.10M | $478.40M | $441.60M | $1.86B | $466.90M |
| Gross Profit | $864.40M | $830.00M | $750.30M | $2.80B | $792.70M |
| Operating Expense | $537.20M | $511.70M | $495.00M | $1.89B | $469.70M |
| Selling and Admin Expenses | $375.60M | $358.70M | $349.70M | $1.29B | $321.50M |
| Research & Development | $161.60M | $153.00M | $145.30M | $599.10M | $148.20M |
| Operating Profit | $327.20M | $318.30M | $255.30M | $911.80M | $323.00M |
| Net Non-Operating Interest Income (Expense) | $11.20M | $13.90M | $16.40M | $94.40M | $19.30M |
| Non-Operating Interest Income | $14.30M | $16.90M | $19.50M | $112.70M | $23.50M |
| Non-Operating Interest Expense | $3.10M | $3.00M | $3.10M | $18.30M | $4.20M |
| Other Income (Expense) | -$3.70M | -$14.70M | -$2.20M | $82.20M | -$1.60M |
| Earnings from Equity Interest | $0.00 | -$10.00M | $0.00 | $78.10M | $0.00 |
| Other Non-Operating Income (Expenses) | -$3.70M | -$4.70M | -$2.20M | $4.10M | -$1.60M |
| Pretax Profit | $334.70M | $317.50M | $269.50M | $1.09B | $340.70M |
| Tax | $59.60M | $68.40M | $70.00M | $252.10M | $73.40M |
| Net Profit | $275.10M | $249.10M | $199.50M | $836.30M | $267.30M |
| Profit from Continuing Operations | $275.10M | $249.10M | $199.50M | $836.30M | $267.30M |
| Net Income to Parent Company | $275.10M | $249.10M | $199.50M | $836.30M | $267.30M |
| Net Income to Common Stockholders | $275.10M | $249.10M | $199.50M | $836.30M | $267.30M |
| Basic EPS | $0.73 | $0.65 | $0.52 | $2.14 | $0.69 |
| Diluted EPS | $0.72 | $0.64 | $0.51 | $2.09 | $0.68 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $6.24B | $6.46B | $6.63B | $6.34B | $6.34B |
| Total Current Assets | $3.92B | $4.09B | $4.33B | $4.03B | $4.03B |
| Cash and Cash Equivalents & Short-Term Investments | $1.82B | $1.95B | $2.42B | $2.00B | $2.00B |
| -Cash and Cash Equivalents | $961.40M | $1.11B | $1.12B | $917.70M | $917.70M |
| -Short Term Investments | $856.50M | $842.00M | $1.30B | $1.08B | $1.08B |
| Receivables | $1.21B | $1.28B | $1.11B | $1.29B | $1.29B |
| -Accounts Receivable | $1.19B | $1.26B | $1.09B | $1.22B | $1.22B |
| -Taxes Receivable | $19.00M | $25.50M | $16.60M | $73.80M | $73.80M |
| Prepaid Assets | $72.40M | $70.70M | $67.90M | $66.40M | $66.40M |
| Inventory | $770.70M | $726.40M | $693.60M | $629.10M | $629.10M |
| Current Deferred Assets | $21.80M | $22.10M | $20.10M | $20.00M | $20.00M |
| Other Current Assets | $28.00M | $37.20M | $29.70M | $29.20M | $29.20M |
| Total Non-Current Assets | $2.32B | $2.37B | $2.30B | $2.31B | $2.31B |
| Net PPE | $1.63B | $1.67B | $1.63B | $1.64B | $1.64B |
| -Gross PPE | $2.60B | $2.62B | $2.54B | $2.50B | $2.50B |
| -Accumulated Depreciation | -$970.40M | -$959.40M | -$905.90M | -$858.80M | -$858.80M |
| Investments and Advances | $217.50M | $209.50M | $219.50M | $218.00M | $218.00M |
| -Available for Sale Securities | $217.50M | $209.50M | – | – | – |
| Non-Current Prepaid Assets | $24.10M | $24.00M | $23.80M | $17.20M | $17.20M |
| Goodwill and Other Intangible Assets | $131.30M | $141.10M | $104.90M | $95.00M | $95.00M |
| -Goodwill | $24.00M | $24.10M | $24.20M | $24.20M | $24.20M |
| -Other Intangible Assets | $107.30M | $117.00M | $80.70M | $70.80M | $70.80M |
| Non-Current Deferred Assets | $305.40M | $304.10M | $296.10M | $295.60M | $295.60M |
| Other Non-Current Assets | $17.70M | $24.80M | $24.50M | $43.50M | $43.50M |
| Total Liabilities | $3.70B | $3.83B | $3.68B | $3.59B | $3.59B |
| Total Current Liabilities | $2.25B | $2.36B | $2.22B | $2.14B | $2.14B |
| Payables | $370.50M | $468.40M | $449.40M | $380.20M | $380.20M |
| -Accounts Payable | $308.50M | $423.80M | $394.30M | $344.30M | $344.30M |
| -Total Tax Payable | $62.00M | $44.60M | $55.10M | $35.90M | $35.90M |
| Current Accrued Expenses | $1.80B | $1.80B | $1.70B | $1.68B | $1.68B |
| Short-Term Debt and Capital Lease Obligation | $20.70M | $20.70M | $20.50M | $21.60M | $21.60M |
| -Current Capital Lease Obligation | $20.70M | $20.70M | $20.50M | $21.60M | $21.60M |
| Current Deferred Liabilities | $21.80M | $22.10M | $20.10M | $27.70M | $27.70M |
| Other Current Liabilities | $6.60M | $9.20M | $7.60M | – | – |
| Total Non-Current Liabilities | $1.45B | $1.48B | $1.45B | $1.45B | $1.45B |
| Long Term Accounts Payable and Other Payables | $31.30M | $51.10M | $51.30M | $46.60M | $46.60M |
| Long Term Debt and Capital Lease Obligation | $1.37B | $1.38B | $1.36B | $1.37B | $1.37B |
| -Long Term Debt | $1.24B | $1.24B | $1.24B | $1.24B | $1.24B |
| -Long Term Capital Lease Obligation | $128.50M | $134.90M | $122.50M | $127.20M | $127.20M |
| Non-Current Liabilities | $19.90M | $20.00M | $20.80M | $20.60M | $20.60M |
| Other Non-Current Liabilities | $27.40M | $27.40M | $16.20M | $16.10M | $16.10M |
| Total Equity | $2.54B | $2.62B | $2.96B | $2.75B | $2.75B |
| Stockholders' Equity | $2.54B | $2.62B | $2.96B | $2.75B | $2.75B |
| Capital Stock | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Common Stock | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.43B | $2.38B | $2.34B | $2.28B | $2.28B |
| Retained Earnings | $3.16B | $2.88B | $2.63B | $2.43B | $2.43B |
| Less: Treasury Stock | -$3.13B | -$2.73B | -$2.12B | -$2.08B | -$2.08B |
| Gains/Losses Not Affecting Retained Earnings | $85.50M | $90.00M | $106.20M | $115.00M | $115.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.12B | $269.20M | $525.60M | $1.44B | $294.00M |
| Net cash flow from continuing operations | $1.12B | $269.20M | $525.60M | $1.44B | $294.00M |
| Net Income from Continuing Operations | $723.70M | $249.10M | $199.50M | $836.30M | $267.30M |
| Gain/Loss from Continuing Operations | $10.00M | – | – | -$78.10M | $0.00 |
| Depreciation & Depletion & Amortization | $209.80M | $68.20M | $67.10M | $251.80M | $65.20M |
| Deferred Tax | -$900,000.00 | -$300,000.00 | $300,000.00 | $182.20M | $78.90M |
| Other Non-Cash Items | $9.90M | $800,000.00 | $1.00M | -$14.50M | -$1.40M |
| Change in Working Capital | $48.80M | -$97.60M | $214.40M | $103.40M | -$151.00M |
| -Change in Receivables | $22.70M | -$172.10M | $124.60M | -$201.90M | -$106.20M |
| -Change in Inventory | -$146.80M | -$36.40M | -$65.20M | -$63.70M | -$17.80M |
| -Change in Prepaid Assets | $51.00M | -$19.10M | $51.00M | -$14.80M | -$6.90M |
| -Change in Payables and Accrued Expense | $136.00M | $127.90M | $98.00M | $402.40M | -$11.30M |
| -Change In Other Working Capital | -$14.10M | $2.10M | $6.00M | -$18.60M | -$8.80M |
| Net cash flow from investing | -$45.40M | $329.80M | -$298.50M | $536.00M | $306.60M |
| Net Cash Flow from Continuing Investing Activities | -$45.40M | $329.80M | -$298.50M | $536.00M | $306.60M |
| Net PPE Purchase and Sale | -$214.20M | -$84.70M | -$76.60M | -$363.50M | -$101.90M |
| Net Business Purchase and Sale | -$41.20M | – | – | – | – |
| Net Investment Purchase and Sale | $210.00M | $455.70M | -$221.90M | $898.90M | $408.40M |
| Financing Cash Flow | -$1.02B | -$607.30M | -$25.00M | -$1.69B | -$1.52B |
| Net Cash Flow from Continuing Financing Activities | -$1.02B | -$607.30M | -$25.00M | -$1.69B | -$1.52B |
| Net Common Stock Issuance | -$978.90M | -$603.60M | $12.70M | -$471.90M | -$312.80M |
| Net Other Financing Charges | -$44.90M | -$3.70M | -$37.70M | -$7.00M | -$1.90M |
| Ending Cash Balance | $961.50M | $1.11B | $1.12B | $919.10M | $919.10M |
| Net Change in Cash | $51.20M | -$8.30M | $202.10M | $290.30M | -$921.60M |
| Beginning Cash Balance | $919.10M | $1.12B | $919.10M | $607.30M | $1.84B |
| Effect of Exchange Rate Changes | -$8.80M | -$4.90M | -$2.80M | $21.50M | $3.80M |
| Free Cash Flow | $906.20M | $184.50M | $449.00M | $1.08B | $192.10M |
| Net Other Investing Changes | – | – | – | $600,000.00 | $100,000.00 |
| Net Issuance Payments Of Debt | – | – | – | -$1.21B | – |
No comments yet — be the first to weigh in on DXCM.
Sign in to join the discussion.